FindTrial
Sign In

What is the best surgical treatment for trigger finger? Minimally invasive technique with retinaculotome or open technique

Surgical treatment of trigger finger: minimally invasive technique with retinaculotome versus open technique. Randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-4433szt
Enrollment
Unknown
Registered
2025-03-05
Start date
2025-03-25
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trigger Finger Disorder

Interventions

This is a single-center, assessor-blinded, randomized controlled clinical trial with two parallel arms, involving 104 participants with trigger finger (52 patients in each group). The study compares t
E04.030

Sponsors

Universidade Federal de São Paulo
Lead Sponsor
Universidade Federal de São Paulo
Collaborator

Eligibility

Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Trigger finger in any of the five fingers; over 18 years old; both sexes; trigger finger greater than II according to the green classification.

Exclusion criteria

Exclusion criteria: Associated Dupuytren's disease; previous surgical treatment for trigger finger; patients with associated collagen or autoimmune diseases; presence of joint stiffness in the interphalangeal joints; previous tendon injuries or fractures of the metacarpals or phalanges

Design outcomes

Primary

MeasureTime frame
The functional outcome assessment is expected to find a 10-point difference on the Disabilities of the Arm, Shoulder, and Hand (Quick-DASH) scale the data will be collected before the procedure and at 2, 4, 8, 12, and 24 weeks post-procedure—

Secondary

MeasureTime frame
Complications and treatment failures are expected to show a significant difference between the groups, including surgical complications, pain requiring analgesia, antibiotic use, neurological paresthesias, and tendon injuries. Treatment failures will be defined as any complication requiring a new surgical intervention;Pain intensity assessed by the Visual Analog Scale expecting to find a 2-point difference between the groups the data will be collected before the procedure and at 2, 4, 8, 12, and 24 weeks post-procedure;The questionnaire regarding scar outcome is expected to find an 8-point difference between the groups the data will be collected before the procedure and at 2, 4, 8, 12, and 24 weeks post-procedure;Time to return to usual daily activities expecting to find a difference of more than 2 weeks between the groups—

Countries

Brazil

Contacts

Public ContactWillker de Carvalho

Universidade Federal de São Paulo

wgcarvalho@unifesp.br+55(11)5576-4522

Outcome results

None listed

Source: REBEC (via WHO ICTRP)